Document Detail


Girding for migratory cues: roles of the Akt substrate Girdin in cancer progression and angiogenesis.
MedLine Citation:
PMID:  20132219     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Cell migration is a fundamental aspect of a multitude of physiological and pathological processes, including embryonic development, inflammation, angiogenesis, and cancer progression. A variety of proteins are essential for cell migration, but context-specific signaling pathways and promigratory proteins must now be identified for our understanding of cancer biology to continue to advance. In this review, we focus on the emerging roles of Girdin (also designated KIAA1212, APE, GIV, and HkRP1), a novel component of the phosphatidylinositol 3-kinase (PI3-K)/Akt signaling pathway that is a core-signaling transduction pathway in cancer progression. Girdin is expressed in some types of cancer cells and immature endothelial cells, and is therefore at the crossroads of multiple intracellular processes, including reorganization of the actin cytoskeleton, endocytosis, and modulation of Akt activity, which ultimately lead to cancer invasion and angiogenesis. It also acts as a nonreceptor guanine nucleotide exchange factor (GEF) for Galphai proteins. A significant observation is that Girdin, although vital for cancer progression and postnatal vascular remodelling, is dispensable for cell migratory events during embryonic development. These findings suggest that Girdin and its interacting proteins are potential pharmaceutical targets for cancer therapies and pathological anigiogenesis, including tumor angiogenesis.
Authors:
Liang Weng; Atsushi Enomoto; Maki Ishida-Takagishi; Naoya Asai; Masahide Takahashi
Related Documents :
11205269 - Failure of detection of the tyrosine to histidine substitution at the residue 33 of thy...
15193279 - Hepatocyte growth factor disrupts tight junctions in human breast cancer cells.
17952379 - The inhibition of in vivo tumorigenesis of osteosarcoma (os)-732 cells by antisense hum...
20599779 - Transglutaminase 2: a multi-tasking protein in the complex circuitry of inflammation an...
14571699 - Expression of receptor for advanced glycation end products (rage) in human biliary canc...
21071579 - Micrornas 221/222 and genistein-mediated regulation of arhi tumor suppressor gene in pr...
11905639 - Familial colorectal cancer: pathology and molecular characteristics.
18601519 - Low-cost, multimodal, portable screening system for early detection of oral cancer.
18448189 - What has the meta-analysis contributed to today's standard of care in the treatment of ...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Review     Date:  2010-02-02
Journal Detail:
Title:  Cancer science     Volume:  101     ISSN:  1349-7006     ISO Abbreviation:  Cancer Sci.     Publication Date:  2010 Apr 
Date Detail:
Created Date:  2010-08-13     Completed Date:  2010-09-29     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101168776     Medline TA:  Cancer Sci     Country:  England    
Other Details:
Languages:  eng     Pagination:  836-42     Citation Subset:  IM    
Affiliation:
Department of Pathology, Nagoya University Graduate School of Medicine, Showa-ku, Nagoya, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
1-Phosphatidylinositol 3-Kinase / metabolism
Animals
Cell Movement* / physiology
Disease Progression*
Endothelial Cells / metabolism
Female
Humans
Neoplasms / blood supply*,  metabolism*
Neoplastic Processes
Neovascularization, Pathologic*
Pregnancy
Proto-Oncogene Proteins c-akt / metabolism*
Signal Transduction
Chemical
Reg. No./Substance:
EC 2.7.1.137/1-Phosphatidylinositol 3-Kinase; EC 2.7.11.1/Proto-Oncogene Proteins c-akt

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Combination of RET siRNA and irinotecan inhibited the growth of medullary thyroid carcinoma TT cells...
Next Document:  Biased usage of BV gene families of T-cell receptors of WT1 (Wilms' tumor gene)-specific CD8 T cells...